EXECUTIVE OFFICER LEVEL CHIEF FINANCIAL OFFICER Palomar Medical Technologies, Inc. 2012 Incentive Compensation Program Operating Period - January 1, 2012 to December 31, 2012

 

 

The amount of bonus the Chief Financial Officer (“CFO”) receives will depend on the 2012 actual performance of Palomar as compared to the Palomar 2012 Operating Plan (“the Plan”) and the CFO’s contribution toward achieving the Plan.  The payout is calculated based on the CFO’s 2012 base salary that was effective as of January 1, 2012.

Upon Palomar achieving the Bonus Levels as described below, the CFO’s bonus amount will be adjusted based on the CFO’s contribution toward achieving the Plan, including, but not limited to, the following objectives:

-

Launch two additional products in the professional market

-

Support strength of our products with clinical studies, white papers and luminary support

-

Increase North America sales by strengthening and expanding sales force

-

Increase international sales by supporting international offices

-

Increase international sales by supporting and adding distributors

-

Expand distribution for the home wrinkle treatment product to international markets

-

Manage patent litigation cases to maximize chances for favorable outcomes

Up to 50% of base salary if Palomar achieves the Plan results from operations before other income/expense and before taxes (including the P&L charge for this Incentive Compensation Program) (“Target Results of Operations”).

Up to an additional 4.5% of the amount that Palomar exceeds the Target Results of Operations.

The Total Bonus payout shall be no more than 200% of the CFO’s base salary.

 

 

1.

No incentive compensation will paid unless Palomar achieves the Target Results of Operations as listed above.  Even if the Target Results of Operations is achieved, the Compensation Committee of the Board of Directors (BOD) may adjust the incentive compensation based on the individual’s performance.

2.	No incentive compensation will accrue to the benefit of any participant until December 31, 2012, at which time the participant must be an employee of Palomar.

3.	Incentive compensation for the 2012 operating period will be paid by March 15, 2013, unless otherwise determined by the Compensation Committee of the BOD.

4.	Where necessary the Compensation Committee of the BOD may adjust financial results to exclude unusual transactions not deemed to be part of normal current operations.

5.	This Incentive Compensation Program may be modified for any reason without notice to the participant in part or in its entirety by the Compensation Committee of the BOD of Palomar.

6.	Continuance of this particular Incentive Compensation Program beyond December 31, 2012 is not guaranteed.

 

 

 

	Approved by:
	/s/ James G. Martin
	James G. Martin
	Chairman of the Compensation Committee
	Palomar Medical Technologies, Inc.
	Approved by BOD on February 7, 2012

 

 

 

 

Received by:
/s/ Paul S. Weiner
Paul S. Weiner
Chief Financial Officer